Literature DB >> 9648063

Cystinuria subtype and the risk of nephrolithiasis.

P Goodyer1, I Saadi, P Ong, G Elkas, R Rozen.   

Abstract

BACKGROUND: Cystinuria patients may be classified into several subgroups based on the urinary phenotype of heterozygotes. However, the relative risk for nephrolithiasis and the prevalence of SLC3A1 mutations in these subgroups are unknown.
METHODS: Urinary cystine excretion, age at onset of nephrolithiasis and nature of SLC3A1 mutations were assessed prospectively in 23 cystinuria patients identified primarily through the Quebec Newborn Screening Program. Probands were classified as to cystinuria subtype on the basis of parental urinary cystine excretion.
RESULTS: For classical Type I/I cystinuria, both parents excrete cystine in the normal range and probands carry two mutations of the SLC3A1 gene in nearly every case. Between ages 1 to 7 years, mean cystine excretion was high (4566 +/- 480 microns cystine/g creatinine) and exceeded the theoretic threshold for solubility on 70% of visits. Four of eight Type I/I patients began forming stones in the first decade. Type I/III patients (N = 12) excreted less cystine (1544 +/- 163 mumol cystine/g creatinine), exceeded the threshold of urinary cystine solubility less frequently (22% of visits) and had no nephrolithiasis in the first decade; one formed a stone at age 16 years. Only one SLC3A1 mutation was identified in this group. Two Type II/N cystinuria children were identified. In these families, the same level of relatively high excretion (> 600 mumol cystine/g creatinine) was noted in two or three generations, but no SLC3A1 mutations were identified.
CONCLUSIONS: Classical recessive Type I/I cystinuria is genetically and phenotypically distinct from the other subtypes (Type I/III and Type II/N) identified in our population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648063     DOI: 10.1046/j.1523-1755.1998.00957.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  A sporadic case of cystinuria, respiratory chain and growth hormone deficiencies.

Authors:  Marco Zaffanello; Renzo Beghini; Giorgio Zamboni; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714

2.  Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.

Authors:  Erik Fjellstedt; Lotta Harnevik; Jan-Olof Jeppsson; Hans-Göran Tiselius; Peter Söderkvist; Torsten Denneberg
Journal:  Urol Res       Date:  2003-10-25

Review 3.  Pediatric urolithiasis: causative factors, diagnosis and medical management.

Authors:  Funda Baştuğ; Ruhan Düşünsel
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

4.  Pilot screening programme for cystinuria in the Valencian community.

Authors:  M L Cabello-Tomás; A M García-Gómez; M L Guillén-Domínguez
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

5.  New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype.

Authors:  M Font-Llitjós; M Jiménez-Vidal; L Bisceglia; M Di Perna; L de Sanctis; F Rousaud; L Zelante; M Palacín; V Nunes
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

Review 6.  Cystinuria-a urologist's perspective.

Authors:  Kay Thomas; Kathie Wong; John Withington; Matthew Bultitude; Angela Doherty
Journal:  Nat Rev Urol       Date:  2014-03-25       Impact factor: 14.432

Review 7.  Cystinuria: an inborn cause of urolithiasis.

Authors:  Thomas Eggermann; Andreas Venghaus; Klaus Zerres
Journal:  Orphanet J Rare Dis       Date:  2012-04-05       Impact factor: 4.123

8.  Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.

Authors:  Katherine V Oliver; Annalisa Vilasi; Amandine Maréchal; Shabbir H Moochhala; Robert J Unwin; Peter R Rich
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

Review 9.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.